ClinicalTrials.Veeva

Menu

Follicular Size and Ploidy Observational Study

A

ART Fertility Clinics LLC

Status

Active, not recruiting

Conditions

Follicle Size
Age, Parental

Treatments

Procedure: measuring the size of the follicle at time of follicle aspiration

Study type

Observational

Funder types

Other

Identifiers

NCT04052035
1905-ABU-061-ND

Details and patient eligibility

About

The primary objective is to determine which follicle sizes generate the highest rate of euploid blastocysts.

Full description

The primary objective is to determine which follicle sizes generate the highest rate of euploid blastocysts.

Secondary objectives to be analysed between the different follicle sizes:

  • The number of cumulus oocyte complexes (COCs) retrieved per aspirated follicle size
  • The number of mature oocytes per COC retrieved (maturation rate)
  • The number of normally fertilized oocytes per number of oocytes injected (fertilization rate)
  • Embryo development up to the blastocyst stage
  • Chromosomal status of the biopsied blastocysts
  • Pregnancy rates after euploid blastocyst transfer
  • Miscarriage rate after euploid blastocyst transfer

Most of the studies that looked at the relation between the follicular size and the developmental competence of the corresponding oocyte analysed normal responders with an average age of 35 years and normal BMI levels. However, during the last decades, a clear shift appeared in the patient population that present themselves for a fertility treatment. With many women delaying childbirth, we do not yet know how these advanced maternal age women may benefit from early or late trigger or from different follicular sizes.

Also, the rising prevalence of obesity may impact the follicular growth, which has not been analysed at the individual follicle size before.

For the above described reasons, we believe that the analysis of individual follicles and the developmental competence of the obtained oocyte, may guide us to improve individualized stimulation protocols for different subtypes of infertile patients. To guide us in this individualized process, this initial pilot study will be performed in a population of normal responders and will later be expanded to an infertile population with different characteristics.

Enrollment

24 patients

Sex

Female

Ages

18 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Cycles with PGT-A analysis

  • ICSI (intracytoplasmic sperm injection) only
  • ICSI 40 hours after trigger
  • Fresh oocytes
  • Ejaculates: fresh or frozen: normozoospermia
  • BMI ≤ 35kg/m 2
  • Age ≤ 40 years
  • AMH ≥ 1.1 ng/ml
  • the number of follicles at the day of trigger: max 20 ≥ 11mm
  • Stimulation protocol: Antagonist protocol with Menopur and and Dual trigger of (5.000-10.000IU) hCG and (0.2-0.3 mg) Gonapeptyl
  • Final oocyte maturation trigger when 2-3 follicles reach size 17mm
  • All races
  • Embryo development in the Embryoscope with Global Total media

Exclusion criteria

  • Inability to puncture all follicles from one ovary
  • Endometriosis
  • Hydrosalpinx
  • History of uterine surgery
  • History of previous treatment which may impact the ovarian reserve (adnexal surgery,
  • chemotherapy, radiation...)
  • Time between trigger and pick up deviating from 36 hours
  • < 100.000 motile sperm
  • Last follicular measurement day deviates more than 24 hours from the trigger day

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems